Home Healthcare IT Japan Autoimmune Disease Diagnostics Market Size And Share Report By 2029

Japan Autoimmune Disease Diagnostics Market Size & Outlook, 2025-2029

Japan Autoimmune Disease Diagnostics Market Size

According to Straits Research analysis the Japan Autoimmune Disease Diagnostics Market was valued at USD 131.62 Million in 2024 and is projected to reach USD 196.67 Million by 2029, expanding at a CAGR of 8.5% during the forecast period. The key drivers of this market include the growth in healthcare, pharmaceuticals, and diagnostics industries, utilizing diagnostic tests for early disease detection and treatment. Emerging advancements in technology for diagnostic methods, such as bioinformatics and DNA sequencing, contribute to market growth potential. Sustainable practices and green production in the clinical sector are increasing, further propelling market trends. As home to some globally renowned medical device makers and diagnostic service providers, Japan is poised to become a hub for Autoimmune Disease Diagnostics, positioning itself as a leader in the diagnosis and treatment of complex diseases.

Japan Autoimmune Disease Diagnostics Market Highlights

  • By 2024, Consumables & Assay Kits represented the largest share of the Product market size.
  • Consumables & Assay Kits is expected to remain the key growth driver within Product, registering the fastest CAGR during the forecast period.
  • In 2024, Japan represented 2.39% of the overall global autoimmune disease diagnostics market size.
  • United States is projected to lead the global autoimmune disease diagnostics market size by 2029.
  • Across Asia Pacific, China is anticipated to hold the dominant position in market by 2029.
  • India is forecasted to expand at the fastest pace in Asia Pacific, attaining USD 58503 Million by 2029.
  • 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
  • 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2029
Historical Period 2021-2023
Forecast Period 2025-2029
Market Size In 2024 USD 131.62 Million
Market Size In 2029 USD 196.67 Million
Largest segment Consumables & Assay Kits
Fastest segment Consumables & Assay Kits
Units Revenue in USD Million
CAGR 8.5% (2025-2029)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Japan Autoimmune Disease Diagnostics Market Share By Product

Segmentation Covered

Segments Sub Segments
Product
  1. Consumables & Assay Kits
  2. Instruments
  3. Services
Test type
  1. Antinuclear Antibody Tests
  2. Autoantibody Tests
  3. Complete Blood Count (CBC)
  4. C-reactive Protein (CRP)
  5. Urinalysis
  6. Others Tests
Target disease
  1. Systemic Autoimmune Disease
  2. Localized Autoimmune Disease
Systemic Autoimmune Disease, by Type
  1. Rheumatoid Arthritis
  2. Psoriasis
  3. Systemic Lupus Erythematosus
  4. Multiple Sclerosis
  5. Others
Localized Autoimmune Disease, by Type
  1. Inflammatory Bowel Disease
  2. Type 1 Diabetes
  3. Thyroid
  4. Other Localized Autoimmune Diseases
End User
  1. Clinical Laboratories
  2. Hospitals
  3. Research Laboratories & Institutes
  4. Others
WhatsApp
Chat with us on WhatsApp